![Keith Vendola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Vendola
Finanzdirektor/CFO bei
NERVGEN PHARMA CORP.
Vermögen: - $ am 31.07.2026
Profil
Keith A. Vendola is currently Chief Financial Officer at NervGen Pharma Corp.
Former positions include Senior Director-Business Development at Threshold Pharmaceuticals, Inc., Chief Financial Officer at Wugen, Inc., Head-Corporate Development at DiObex, Inc., Vice President-Finance & Corporate Development at Eiger BioPharmaceuticals, Inc., Chief of Staff & VP-Competitive Strategy at Coherus Oncology, Inc. from 2015 to 2017, Chief Strategy Officer at Rezolute, Inc. from 2020 to 2021, and Chief Financial Officer at IO Biotech, Inc. from 2021 to 2022.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from Dartmouth Medical School, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 27.04.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Keith Vendola
| Unternehmen | Position | Beginn |
|---|---|---|
| NERVGEN PHARMA CORP. | Finanzdirektor/CFO | 27.04.2026 |
Ehemalige bekannte Positionen von Keith Vendola
| Unternehmen | Position | Ende |
|---|---|---|
| IO BIOTECH, INC. | Finanzdirektor/CFO | 09.05.2022 |
| REZOLUTE, INC. | Finanzdirektor/CFO | 06.11.2020 |
| COHERUS ONCOLOGY, INC. | Personalreferent | 01.06.2017 |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Finanzdirektor/CFO | - |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Finanzdirektor/CFO | - |
Ausbildung von Keith Vendola
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Technology Services |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
